H.F. 4516 Summary

• Establishes an opiate stewardship program requiring drug manufacturers to pay an annual fee of one cent per morphine milligram equivalent of opiates sold in Minnesota, collected by the Board of Pharmacy.

• Requires manufacturers to report annually by March 1 the quantity of opiates sold into the state in the previous calendar year, with the Board using CDC morphine equivalent charts to calculate fees.

• Dedicates stewardship fee revenue to a special revenue fund account with automatic annual appropriation to the Commissioner of Human Services for addiction care services.

• Mandates at least 50 percent of revenue fund competitive grants to nonprofit organizations for prescriber education, public awareness, and overdose prevention, with at least 2.5 percent for the Board of Pharmacy and Minnesota prescription monitoring program.

• Creates an Opiate Product Stewardship Advisory Council with 11 voting members including representatives from health professions, courts, treatment facilities, and individuals impacted by opiates, plus 4 nonvoting legislative members, required to submit annual reports to relevant legislative committees.